Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10360384 | 0.88 | RXRA (0.42) | RXRAGRIN1GRIN2BPOLBMAPT | |
| SCHEMBL14617274 | 0.82 | RXRA (0.35) | RXRAGRIN1GRIN2BCYP1A2CYP2D6 | |
| SCHEMBL14617483 | 0.82 | RXRA (0.38) | RXRAGRIN1GRIN2BPOLBCYP1A2 | |
| SCHEMBL10360310 | 0.76 | NOTUM (0.44) | TDP1 | |
| SCHEMBL6132524 | 0.76 | CYP1A2 (0.47) | POLBCYP1A2CYP2C9MAPT | |
| SCHEMBL1259350 | 0.75 | PTGS2 (0.37) | RXRAGRIN1GRIN2BPOLBBLM | |
| SCHEMBL2743397 | 0.75 | RXRA (0.37) | RXRAGRIN1GRIN2BCYP2D6CYP2C9 | |
| SCHEMBL17454712 | 0.75 | S1PR1 (0.34) | RXRAGRIN1GRIN2BPOLBBLM | |
| SCHEMBL1260336 | 0.75 | ALDH1A1 (0.39) | — | |
| SCHEMBL19503068 | 0.74 | MAPKAPK2 (0.43) | POLBBLMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014186027-A1 | PROCESS FOR THE PREPARATION OF TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014158650-A1 | PREPARATION OF TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-10-02 | — | — | WO | disclosed |
| WO-2014158644-A1 | PROCESS FOR THE PREPARATION OF TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-10-02 | — | — | WO | disclosed |
| WO-2014158647-A1 | PREPARATION OF TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-10-02 | — | — | WO | disclosed |
| WO-2014158646-A1 | IMPROVED PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20140275565-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275564-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275504-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275503-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275502-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | DOW AGROSCIENCES LLC (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275564-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | B3GAT3, UGGT1, UGT1A3 | RXRA 150/4885GRIN1 3061/4885GRIN2B 3395/4885 |
| US-20140275504-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | BCR, BCHE, C9 | RXRA 215/4885GRIN1 4321/4885GRIN2B 4027/4885 |
| US-20140275503-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | CA6, CA7, CA4 | RXRA 248/4885GRIN1 4579/4885GRIN2B 3998/4885 |
| US-20140275502-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | BCHE, LRAT, B3GAT3 | RXRA 109/4885GRIN1 3605/4885GRIN2B 3435/4885 |
| US-20140275565-A1 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | UGGT1, UGDH, UGT1A3 | RXRA 286/4885GRIN1 3684/4885GRIN2B 4489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.